Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: Research Summary.

doi:10.1001/jama.2026.4329

← 뒤로

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: Research Summary.

JAMA 2026 p. e264329

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA (2026). Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: Research Summary.. JAMA, e264329. https://doi.org/10.1001/jama.2026.4329

MLA . "Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: Research Summary.." JAMA, 2026, pp. e264329.

PMID 42018317

DOI 10.1001/jama.2026.4329